463-05-002 ISMRM Abstract

PSMA-PET/MRI Tracers in Prostate Cancer Recurrence: Superior Sensitivity of [¹⁸F]F-PSMA-1007 at Low PSA Levels.

Primary: Body - Prostate

Secondary: Physics & Engineering - PET/MR

463-05-002 · Malignant Tumor in the Body · Tuesday, 12 May, 4:00 PM–4:55 PM · Digital Posters Row D

Keywords: Prostate Imaging PSMA-PET Biochemical recurrence PET-MRI

Accepted

Ingerid S Knudtsen¹, Dorothea Druta-Barbatei¹, Bendik S Abrahamsen¹, Trond V Bogsrud², Miguel J Castillejo², Mattijs Elschot¹, Hege S Haugnes², Svein-Inge Helle³, Eivor Hernes⁴, Alfred Honore³, Håkon Johansen⁵, Thomas M Keil⁵, Sverre Langørgen⁵, Anders Ringheim³, Kirsten M Selnæs⁵, Andreas J Tulipan³, Torgrim Tandstad⁵, Tone F Bathen ¹

¹Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway

²University Hospital of North Norway, Tromsø, Norway

³Haukeland University Hospital, Bergen, Norway

⁴Oslo University Hospital, Oslo, Norway

⁵St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway

Presenting Author: Tone F Bathen

Synopsis

Motivation:

Goals:

Approach:

Results:

Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

References

1. Tilki D et al., EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. PartII-2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer. Eur Urol. 2024 Aug;86(2):164-182. doi: 10.1016/j.eururo.2024.04.010. PMID: 38688773. [doi] [pmid]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/463-05-002